Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    SciClone Pharmaceuticals, Inc. (SCLN)

    Price:

    11.15 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    SCLN
    Name
    SciClone Pharmaceuticals, Inc.
    Industry
    Sector
    Price
    11.150
    Market Cap
    0
    Enterprise value
    408.143M
    Currency
    USD
    Ceo
    Full Time Employees
    Website
    Ipo Date
    1992-03-17
    City
    Address

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Invesco BulletShares 2027 High Yield Corporate Bond ETF

    VALUE SCORE:

    11

    Symbol
    BSJR
    Market Cap
    0
    Industry
    Asset Management - Bonds
    Sector
    Financial Services

    2nd position

    Northrim BanCorp, Inc.

    VALUE SCORE:

    15

    Symbol
    NRIM
    Market Cap
    471.857M
    Industry
    Banks - Regional
    Sector
    Financial Services

    The best

    Bank OZK

    VALUE SCORE:

    15

    Symbol
    OZK
    Market Cap
    5.815B
    Industry
    Banks - Regional
    Sector
    Financial Services
    FUNDAMENTALS
    P/E
    18.228
    P/S
    0
    P/B
    2.601
    Debt/Equity
    0
    EV/FCF
    -3.967
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    -0.839
    Earnings yield
    0.055
    Debt/assets
    0
    FUNDAMENTALS
    Net debt/ebidta
    -3.827
    Interest coverage
    0
    Research And Developement To Revenue
    0.094
    Intangile to total assets
    0.127
    Capex to operating cash flow
    0.019
    Capex to revenue
    0.004
    Capex to depreciation
    0.658
    Return on tangible assets
    0.146
    Debt to market cap
    Piotroski Score
    FUNDAMENTALS
    PEG
    0.182
    P/CF
    16.223
    P/FCF
    0
    RoA %
    12.703
    RoIC %
    13.887
    Gross Profit Margin %
    85.697
    Quick Ratio
    6.775
    Current Ratio
    7.403
    Net Profit Margin %
    19.194
    Net-Net
    2.948
    FUNDAMENTALS PER SHARE
    FCF per share
    0.674
    Revenue per share
    3.187
    Net income per share
    0.612
    Operating cash flow per share
    0.687
    Free cash flow per share
    0.674
    Cash per share
    2.691
    Book value per share
    4.287
    Tangible book value per share
    3.673
    Shareholders equity per share
    4.287
    Interest debt per share
    0
    TECHNICAL
    52 weeks high
    11.425
    52 weeks low
    8.550
    Current trading session High
    11.200
    Current trading session Low
    11.150
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    DESCRIPTION

    SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.

    NEWS